HomeCONCORDBIO • NSE
add
Concord Biotech Ltd
Nakaraang pagsara
₹1,795.30
Sakop ng araw
₹1,751.00 - ₹1,811.30
Sakop ng taon
₹1,345.00 - ₹2,664.00
Market cap
183.98B INR
Average na Volume
265.00K
P/E ratio
49.41
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.30B | 34.77% |
Gastos sa pagpapatakbo | 962.43M | 13.00% |
Net na kita | 1.40B | 47.75% |
Net profit margin | 32.66 | 9.63% |
Kita sa bawat share | 13.42 | 47.80% |
EBITDA | 1.89B | 33.07% |
Aktuwal na % ng binabayarang buwis | 23.51% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.18B | 12.80% |
Kabuuang asset | 20.34B | 19.61% |
Kabuuang sagutin | 2.22B | 27.27% |
Kabuuang equity | 18.13B | — |
Natitirang share | 104.61M | — |
Presyo para makapag-book | 10.36 | — |
Return on assets | — | — |
Return on capital | 25.78% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.40B | 47.75% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Itinatag
2000
Website
Mga Empleyado
1,377
